Literature DB >> 21256570

Urologist practice styles in the initial evaluation of elderly men with benign prostatic hyperplasia.

Seth A Strope1, Sean P Elliott, Alex Smith, John T Wei, Timothy J Wilt, Christopher S Saigal.   

Abstract

OBJECTIVES: To investigate the degree to which expenditures on symptom evaluations vary among urologists and the factors associated with such variation. As the medical and surgical specialists for men with lower urinary tract symptoms (LUTS), urologists provide testing to evaluate symptoms and determine therapy.
METHODS: We developed a cohort of men with an initial urologist visit for benign prostatic hyperplasia (BPH) from a 5% sample of Medicare patients (1999-2007) and established a physician level factor, practice style, as a function of average per patient expenditures. We then determined which AUA BPH guideline elements explained variation in quantity and expenditures for BPH testing, and also examined the impact of patient and physician factors on practice style.
RESULTS: A nearly 15-fold variation in urologists' average per-patient expenditures existed ($35 to $527 per month; Median $92). Practice styles were associated with physician (P < .01 all examined variables) and patient (P < .01 for comorbidity, race/ethnicity, and socioeconomic status) factors. Guideline recommended care was provided at lower rates by the lowest expenditure urologists compared with middle- to highest-intensity urologists (P < .01). Practice style variations were attributable mainly to differences in tests characterized by the guidelines as optional and not-recommended (P < .01).
CONCLUSIONS: Expenditures for BPH evaluations vary substantially by geography, practice setting, and experience and are accounted for largely by differences in the use of optional and not-routinely recommended tests. Greater standardization could enhance patient care and reduce health care costs.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21256570      PMCID: PMC3074578          DOI: 10.1016/j.urology.2010.07.485

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  13 in total

1.  Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly population.

Authors:  Joan L Warren; Carrie N Klabunde; Deborah Schrag; Peter B Bach; Gerald F Riley
Journal:  Med Care       Date:  2002-08       Impact factor: 2.983

2.  National and state trends in quality of care for acute myocardial infarction between 1994-1995 and 1998-1999: the medicare health care quality improvement program.

Authors:  Dale R Burwen; Deron H Galusha; Jennifer M Lewis; Marjorie R Bedinger; Martha J Radford; Harlan M Krumholz; JoAnne Micale Foody
Journal:  Arch Intern Med       Date:  2003-06-23

3.  On the status of the Prostate Disease Assessment Team.

Authors:  J E Wennberg
Journal:  Health Serv Res       Date:  1990-12       Impact factor: 3.402

4.  Process of care and outcomes for elderly patients hospitalized with peptic ulcer disease: results from a quality improvement project.

Authors:  J Brock; A Sauaia; D Ahnen; W Marine; W Schluter; B R Stevens; J D Scinto; H Karp; D Bratzler
Journal:  JAMA       Date:  2001 Oct 24-31       Impact factor: 56.272

5.  The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association.

Authors:  M J Barry; F J Fowler; M P O'Leary; R C Bruskewitz; H L Holtgrewe; W K Mebust; A T Cockett
Journal:  J Urol       Date:  1992-11       Impact factor: 7.450

Review 6.  Comprehensive patient evaluation for benign prostatic hyperplasia.

Authors:  J V Jepsen; R C Bruskewitz
Journal:  Urology       Date:  1998-04       Impact factor: 2.649

7.  Neighborhood of residence and incidence of coronary heart disease.

Authors:  A V Diez Roux; S S Merkin; D Arnett; L Chambless; M Massing; F J Nieto; P Sorlie; M Szklo; H A Tyroler; R L Watson
Journal:  N Engl J Med       Date:  2001-07-12       Impact factor: 91.245

Review 8.  Benign prostatic hyperplasia in primary care: what you need to know.

Authors:  Arthur L Burnett; Alan J Wein
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

9.  Benign prostatic hyperplasia: diagnosis and treatment. Agency for Health Care Policy and Research.

Authors:  J D McConnell; M J Barry; R C Bruskewitz
Journal:  Clin Pract Guidel Quick Ref Guide Clin       Date:  1994-02

10.  A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients.

Authors:  Carrie N Klabunde; Julie M Legler; Joan L Warren; Laura-Mae Baldwin; Deborah Schrag
Journal:  Ann Epidemiol       Date:  2007-05-25       Impact factor: 3.797

View more
  7 in total

1.  Changes in initial expenditures for benign prostatic hyperplasia evaluation in the Medicare population: a comparison to overall Medicare inflation.

Authors:  Adam S Bellinger; Sean P Elliott; Liu Yang; John T Wei; Christopher S Saigal; Alexandria Smith; Timothy J Wilt; Seth A Strope
Journal:  J Urol       Date:  2012-03-15       Impact factor: 7.450

Review 2.  Self-report measurement of lower urinary tract symptoms: a commentary on the literature since 2011.

Authors:  James W Griffith
Journal:  Curr Urol Rep       Date:  2012-12       Impact factor: 3.092

3.  Evaluative care guideline compliance is associated with provision of benign prostatic hyperplasia surgery.

Authors:  Seth A Strope; John T Wei; Alexandria Smith; Timothy J Wilt; Christopher S Saigal; Sean P Elliott
Journal:  Urology       Date:  2012-05-18       Impact factor: 2.649

4.  Urologist compliance with AUA best practice guidelines for benign prostatic hyperplasia in Medicare population.

Authors:  Seth A Strope; Sean P Elliott; Christopher S Saigal; Alex Smith; Timothy J Wilt; John T Wei
Journal:  Urology       Date:  2011-05-23       Impact factor: 2.649

5.  Cost of illness of medically treated benign prostatic hyperplasia in Hungary.

Authors:  Fanni Rencz; Ágnes Kovács; Valentin Brodszky; László Gulácsi; Zalán Németh; Gábor János Nagy; János Nagy; István Buzogány; Géza Böszörményi-Nagy; Attila Majoros; Péter Nyirády
Journal:  Int Urol Nephrol       Date:  2015-06-21       Impact factor: 2.370

6.  Initial treatment of men with newly diagnosed lower urinary tract dysfunction in the Veterans Health Administration.

Authors:  Bradley A Erickson; Xin Lu; Mary Vaughan-Sarrazin; Karl J Kreder; Benjamin N Breyer; Peter Cram
Journal:  Urology       Date:  2013-11-25       Impact factor: 2.649

7.  Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia.

Authors:  Fakhri Rahman; Ida Bagus Putra; Chaidir Arif Mochtar; Nur Rasyid
Journal:  Prostate Int       Date:  2018-02-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.